2025全球高血压报告_342页_6mb

Summary of the Global Report on Hypertension 2025

Core Content

The Global Report on Hypertension 2025: High Stakes – Turning Evidence into Action is a comprehensive publication by the World Health Organization (WHO) aimed at highlighting the global burden of hypertension and the need for urgent, coordinated action to prevent and control it. The report emphasizes that hypertension is a major public health threat, responsible for millions of deaths and disabilities annually, and that it is often asymptomatic, making early detection and management critical.

Main Points

• Hypertension as a Silent Killer: It is a leading risk factor for heart attacks, strokes, chronic kidney disease, and dementia. It often goes undetected until serious health issues arise.
• Global Prevalence and Control Rates: In 2024, approximately 1.4 billion adults aged 30–79 years were affected by hypertension globally, yet only 23% (320 million) had their blood pressure effectively controlled.
• Economic Burden: Hypertension imposes a heavy financial burden on individuals, families, and economies. In low- and middle-income countries, the economic losses due to cardiovascular diseases, including hypertension, were estimated at US$3.7 trillion from 2011 to 2025.
• Progress in Some Countries: A few countries have demonstrated significant progress in hypertension control through integrated health systems, political leadership, and community engagement. Examples include:
  • Republic of Korea: Achieved 59% national blood pressure control rate in 2022 through low-cost medications and capped co-payments.
  • Philippines: Successfully implemented the WHO HEARTS technical package in primary care, achieving 65% control rate in a regional demonstration project.
  • Bangladesh: Increased control from 18% in 2020 to 58% in 2025 by embedding hypertension services into essential health packages.
• Barriers to Control: Many countries face systemic challenges in hypertension prevention and control, including:
  • Lack of effective prevention policies.
  • Limited access to validated blood pressure devices.
  • Inadequate treatment protocols and trained health workers.
  • Poor budgetary allocation and supply chain management.
  • Insufficient financial protection for patients, especially in low- and middle-income countries.
  • Weak information systems for monitoring care quality and equity.

Key Recommendations

The report outlines five key recommendations for countries to achieve fast and sustainable results in hypertension prevention and control:

1. Integrate hypertension interventions into universal health coverage (UHC) reforms.
2. Improve access to affordable antihypertensive medicines and validated blood pressure measurement devices.
3. Invest in health workforce development and expand team-based care models.
4. Strengthen health information systems to monitor treatment and control rates.
5. Raise public awareness about hypertension and make prevention and control a shared responsibility.

Strategic Entry Points for UHC

Hypertension prevention and control can be strategically integrated into UHC health benefit packages at various stages, including:

• Governance and prioritization.
• Costing and implementation.
• Monitoring and evaluation.

These entry points are crucial for ensuring that hypertension services are accessible, affordable, and sustainable.

Importance of Access to Medicines

Access to essential antihypertensive medicines is a cornerstone of hypertension control. The report highlights that:

• In high-income countries, 93% of the 5 essential antihypertensive medicines are generally available.
• In low-income countries, this availability drops to 28%.
• Systemic reforms in the pharmaceutical value chain, including regulatory capacity, pricing transparency, and procurement efficiency, are essential to improve access.

Role of Prevention and Integrated Care

The report underscores that:

• Prevention and treatment of hypertension are cost-effective and affordable.
• Integrated care models, especially in primary care, are vital for managing hypertension alongside other NCDs and maternal health conditions.
• Political commitment, sustainable investment, and community engagement are key to achieving long-term success in hypertension control.

Conclusion

This report serves as a practical roadmap for countries to scale up hypertension prevention and control efforts. It calls for urgent action, policy reform, and systemic change to address the global health crisis caused by uncontrolled hypertension. By implementing the recommendations, countries can significantly reduce the health and economic burden associated with hypertension and move closer to achieving universal health coverage.

Key Information

• ISBN: 978-92-4-011556-9 (electronic), 978-92-4-011557-6 (print).
• Suggested Citation: Global report on hypertension 2025: high stakes – turning evidence into action. Geneva: World Health Organization; 2025.
• License: CC BY-NC-SA 3.0 IGO.
• Financial Support: Provided by Resolve to Save Lives, funded by Bloomberg Philanthropies.
• Contributors: WHO staff and partners from various sectors, including academia, NGOs, and the private sector.

Annexes

• Annex 1: Country profiles and hypertension profiles.
• Annex 2: Methodology of scoping reviews of literature.
• Annex 3: Key steps to strengthen the value chain for hypertension medicines.

This report is directed at policy-makers, public health practitioners, clinical professionals, and development partners to guide action and improve health outcomes globally.